S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel

Compare Stocks

Date Range: 

 Edwards LifesciencesAlign TechnologyColoplast A/SZimmer BiometIntuitive Surgical
SymbolNYSE:EWNASDAQ:ALGNOTCMKTS:CLPBYNYSE:ZBHNASDAQ:ISRG
Price Information
Current Price$112.16$589.61$15.91$146.36$331.50
50-Day Moving Average$116.01$688.31$16.98$146.81$354.85
52-Week Low$70.92$322.87$13.64$130.05$217.67
52-Week High$123.27$737.45$18.90$180.36$362.34
MarketRank™
Overall Score2.22.31.52.62.2
Analysis Score2.32.50.03.42.2
Community Score4.94.84.04.84.9
Dividend Score0.00.02.51.70.0
Ownership Score2.52.50.01.72.5
Earnings & Valuation Score1.31.91.31.31.3
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyHold
Consensus Price Target$118.44$688.85$1,144.00$179.95$327.89
% Upside from Price Target5.60% upside16.83% upside7,092.71% upside22.95% upside-1.09% downside
Trade Information
Market Cap$69.91 billion$46.59 billion$34.35 billion$30.57 billion$118.34 billion
Beta1.081.680.281.321.05
Average Volume2,459,815586,07372,8091,294,6521,627,493
Sales & Book Value
Annual Revenue$4.39 billion$2.47 billion$2.76 billion$7.02 billion$4.36 billion
Price / Sales15.9418.8512.444.3527.15
Cashflow$1.91 per share$19.40 per share$0.30 per share$14.38 per share$3.73 per share
Price / Cash58.8130.4052.4710.1888.99
Book Value$7.34 per share$41.01 per share$0.48 per share$58.85 per share$82.90 per share
Price / Book15.2814.3833.142.494.00
Profitability
Net Income$823.40 million$1.78 billion$585.21 million$-138.90 million$1.06 billion
EPS$1.86$22.41$0.30$5.67$8.82
Trailing P/E Ratio48.1467.1556.8033.5724.78
Forward P/E Ratio43.6450.5744.1816.8422.85
P/E Growth3.402.98N/A2.137.54
Net Margins29.69%20.10%21.62%11.61%31.43%
Return on Equity (ROE)29.73%21.42%69.30%12.85%16.18%
Return on Assets (ROA)19.10%14.17%33.77%6.52%14.23%
Dividend
Annual PayoutN/AN/A$0.22$0.96N/A
Dividend YieldN/AN/A1.38%0.66%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/A73.33%16.93%N/A
Years of Consecutive Dividend GrowthN/AN/AN/A1 YearsN/A
Debt
Debt-to-Equity Ratio0.12%N/A0.02%0.54%N/A
Current Ratio3.75%1.32%1.29%1.83%5.99%
Quick Ratio2.89%1.21%0.90%0.96%5.42%
Ownership Information
Institutional Ownership Percentage80.13%83.32%0.10%88.69%83.91%
Insider Ownership Percentage1.35%0.70%N/A0.56%0.80%
Miscellaneous
Employees14,90018,07012,50020,0008,081
Shares Outstanding623.33 million79.01 million2.16 billion208.84 million356.97 million
Next Earnings Date10/27/2021 (Confirmed)10/27/2021 (Confirmed)N/A11/4/2021 (Confirmed)10/19/2021 (Confirmed)
OptionableOptionableOptionableNot OptionableOptionableOptionable
SourceHeadline
Price To Earnings Ratio Insights For Intuitive SurgicalPrice To Earnings Ratio Insights For Intuitive Surgical
benzinga.com - October 15 at 2:43 PM
Massachusetts company will buy Bolder Surgical for $160MMassachusetts company will buy Bolder Surgical for $160M
dailycamera.com - October 14 at 7:53 PM
Intuitive Surgical, Inc. (ISRG) Earnings Expected to Grow: What to Know Ahead of Next Weeks ReleaseIntuitive Surgical, Inc. (ISRG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
finance.yahoo.com - October 12 at 7:20 PM
Should Intuitive Surgicals Shareholders Worry About the Delta Variant?Should Intuitive Surgical's Shareholders Worry About the Delta Variant?
finance.yahoo.com - October 12 at 2:14 PM
3 No-Brainer Stocks to Invest $1,000 in Right Now3 No-Brainer Stocks to Invest $1,000 in Right Now
finance.yahoo.com - October 11 at 9:43 AM
What to Watch in Intuitive Surgicals Upcoming Earnings ReportWhat to Watch in Intuitive Surgical's Upcoming Earnings Report
fool.com - October 10 at 8:44 AM
Intuitive Surgical Stock Earns Composite Rating UpgradeIntuitive Surgical Stock Earns Composite Rating Upgrade
finance.yahoo.com - October 8 at 6:29 PM
Top Analyst Reports for Pfizer, American Tower & Intuitive SurgicalTop Analyst Reports for Pfizer, American Tower & Intuitive Surgical
msn.com - October 7 at 5:56 PM
Intuitive Surgical Inc. (ISRG) Has Recovered 36.63% From Its Low: Is This The Beginning Of A Trend?Intuitive Surgical Inc. (ISRG) Has Recovered 36.63% From Its Low: Is This The Beginning Of A Trend?
stocksregister.com - October 7 at 5:56 PM
Intuitive Surgical, Inc. (ISRG) Moves to Buy: Rationale Behind the UpgradeIntuitive Surgical, Inc. (ISRG) Moves to Buy: Rationale Behind the Upgrade
finance.yahoo.com - October 7 at 5:56 PM
Intuitive Surgical (NASDAQ:ISRG) Stock Rating Upgraded by Zacks Investment ResearchIntuitive Surgical (NASDAQ:ISRG) Stock Rating Upgraded by Zacks Investment Research
marketbeat.com - October 7 at 10:17 AM
Intuitive Surgical (NASDAQ:ISRG) Stock Rating Lowered by TheStreetIntuitive Surgical (NASDAQ:ISRG) Stock Rating Lowered by TheStreet
marketbeat.com - October 7 at 7:05 AM
The Top 3 Buy & Hold Healthcare Stocks for October (ISRG)The Top 3 Buy & Hold Healthcare Stocks for October (ISRG)
marketbeat.com - October 6 at 8:35 PM
With an Understated 30% Profit Margin, Intuitive Surgical, Inc. (NASDAQ:ISRG) may be a Great Find for InvestorsWith an Understated 30% Profit Margin, Intuitive Surgical, Inc. (NASDAQ:ISRG) may be a Great Find for Investors
finance.yahoo.com - October 6 at 1:06 PM
Why is Intuitive Surgical Trending?Why is Intuitive Surgical Trending?
finance.yahoo.com - October 6 at 1:06 PM
Intuitive Surgical (NASDAQ:ISRG) Price Target Cut to $310.00Intuitive Surgical (NASDAQ:ISRG) Price Target Cut to $310.00
americanbankingnews.com - October 5 at 10:12 AM
3 No-Brainer Stocks to Buy in October3 No-Brainer Stocks to Buy in October
finance.yahoo.com - October 5 at 7:06 AM
Why Intuitive Surgical Stock Tumbled TodayWhy Intuitive Surgical Stock Tumbled Today
finance.yahoo.com - October 4 at 9:04 PM
Intuitive Surgical Revenue Bounces Back After Pandemic Pause Intuitive Surgical Revenue Bounces Back After Pandemic Pause
marketbeat.com - October 4 at 6:00 AM
3 Automation Stocks to Buy Right Now3 Automation Stocks to Buy Right Now
stocknews.com - October 1 at 2:23 PM
Intuitive Surgical (NASDAQ:ISRG) Cut to "Neutral" at CitigroupIntuitive Surgical (NASDAQ:ISRG) Cut to "Neutral" at Citigroup
americanbankingnews.com - October 1 at 8:52 AM
Noteworthy Thursday Option Activity: BSIG, ISRG, DENoteworthy Thursday Option Activity: BSIG, ISRG, DE
nasdaq.com - September 30 at 4:11 PM
5 Top Stocks for October5 Top Stocks for October
finance.yahoo.com - September 30 at 4:11 PM
Intuitive Surgical Inc. stock underperforms Monday when compared to competitorsIntuitive Surgical Inc. stock underperforms Monday when compared to competitors
marketwatch.com - September 29 at 5:22 AM
Hedge Funds Are Piling Into Intuitive Surgical, Inc. (ISRG)Hedge Funds Are Piling Into Intuitive Surgical, Inc. (ISRG)
finance.yahoo.com - September 28 at 7:21 PM
Intuitive Surgical (NASDAQ:ISRG) Earns Buy Rating from Analysts at Raymond JamesIntuitive Surgical (NASDAQ:ISRG) Earns Buy Rating from Analysts at Raymond James
americanbankingnews.com - September 28 at 1:20 PM
Intuitive Surgical (NASDAQ:ISRG) Receives New Coverage from Analysts at Raymond JamesIntuitive Surgical (NASDAQ:ISRG) Receives New Coverage from Analysts at Raymond James
marketbeat.com - September 28 at 12:23 PM
Medical Device Maker Broncus Gets Financial Breathing Room from IPOMedical Device Maker Broncus Gets Financial Breathing Room from IPO
benzinga.com - September 27 at 6:07 PM
Will Intuitive Surgical Be a Trillion-Dollar Stock by 2035?Will Intuitive Surgical Be a Trillion-Dollar Stock by 2035?
fool.com - September 26 at 8:48 AM
After Doubling Since 2019, Is Intuitive Surgical Stock Too Expensive?After Doubling Since 2019, Is Intuitive Surgical Stock Too Expensive?
finance.yahoo.com - September 25 at 10:05 AM
3 High-Tech Healthcare Stocks to Buy Now (ISRG)3 High-Tech Healthcare Stocks to Buy Now (ISRG)
marketbeat.com - August 6 at 1:52 PM
DateCompanyBrokerageAction
10/13/2021Coloplast A/SBarclays
Reiterated Rating
10/5/2021Zimmer BiometBarclays
Lower Price Target
10/5/2021Intuitive SurgicalMorgan Stanley
Lower Price Target
10/1/2021Zimmer BiometCitigroup
Lower Price Target
10/1/2021Intuitive SurgicalCitigroup
Downgrade
9/28/2021Intuitive SurgicalRaymond James
Initiated Coverage
9/14/2021Zimmer BiometRobert W. Baird
Reiterated Rating
9/14/2021Zimmer BiometRaymond James
Initiated Coverage
9/10/2021Coloplast A/SBarclays
Reiterated Rating
8/26/2021Intuitive SurgicalSVB Leerink
Boost Price Target
8/19/2021Coloplast A/SCredit Suisse Group
Reiterated Rating
8/19/2021Coloplast A/SJPMorgan Chase & Co.
Reiterated Rating
8/11/2021Coloplast A/SKepler Capital Markets
Downgrade
8/4/2021Zimmer BiometCanaccord Genuity
Lower Price Target
8/4/2021Zimmer BiometSVB Leerink
Lower Price Target
8/4/2021Zimmer BiometOppenheimer
Lower Price Target
8/3/2021Edwards LifesciencesThe Goldman Sachs Group
Boost Price Target
8/3/2021Zimmer BiometStifel Nicolaus
Lower Price Target
8/2/2021Edwards LifesciencesRaymond James
Boost Price Target
7/30/2021Edwards LifesciencesCredit Suisse Group
Boost Price Target
7/30/2021Edwards LifesciencesMorgan Stanley
Boost Price Target
7/30/2021Edwards LifesciencesOppenheimer
Boost Price Target
7/30/2021Edwards LifesciencesStifel Nicolaus
Boost Price Target
7/30/2021Edwards LifesciencesUBS Group
Boost Price Target
7/30/2021Edwards LifesciencesSVB Leerink
Boost Price Target
7/30/2021Edwards LifesciencesCanaccord Genuity
Boost Price Target
7/30/2021Edwards LifesciencesJefferies Financial Group
Boost Price Target
7/30/2021Edwards LifesciencesWells Fargo & Company
Boost Price Target
7/30/2021Edwards LifesciencesDeutsche Bank Aktiengesellschaft
Boost Price Target
7/29/2021Align TechnologyWilliam Blair
Reiterated Rating
7/29/2021Align TechnologyCredit Suisse Group
Boost Price Target
7/29/2021Align TechnologyPiper Sandler
Boost Price Target
7/27/2021Edwards LifesciencesPiper Sandler
Boost Price Target
7/23/2021Edwards LifesciencesCowen
Boost Price Target
7/22/2021Intuitive SurgicalDeutsche Bank Aktiengesellschaft
Boost Price Target
7/21/2021Intuitive SurgicalSVB Leerink
Boost Price Target
7/21/2021Intuitive SurgicalUBS Group
Boost Price Target
7/21/2021Intuitive SurgicalJPMorgan Chase & Co.
Boost Price Target
7/21/2021Intuitive SurgicalBank of America
Boost Price Target
7/21/2021Intuitive SurgicalEvercore ISI
Boost Price Target
7/21/2021Intuitive SurgicalMorgan Stanley
Boost Price Target
7/21/2021Intuitive SurgicalWells Fargo & Company
Boost Price Target
7/21/2021Intuitive SurgicalRobert W. Baird
Boost Price Target
7/21/2021Intuitive SurgicalCitigroup
Boost Price Target
7/21/2021Intuitive SurgicalPiper Sandler
Boost Price Target
7/20/2021Edwards LifesciencesSVB Leerink
Boost Price Target
7/15/2021Coloplast A/SBarclays
Reiterated Rating
7/14/2021Intuitive SurgicalThe Goldman Sachs Group
Boost Price Target
7/14/2021Intuitive SurgicalStifel Nicolaus
Boost Price Target
7/9/2021Align TechnologyStephens
Upgrade
7/8/2021Align TechnologyExane BNP Paribas
Initiated Coverage
7/8/2021Align TechnologyBNP Paribas
Initiated Coverage
6/7/2021Intuitive SurgicalWells Fargo & Company
Boost Price Target
5/25/2021Zimmer BiometBarclays
Initiated Coverage
5/24/2021Edwards LifesciencesBarclays
Initiated Coverage
5/18/2021Coloplast A/SBerenberg Bank
Reiterated Rating
5/17/2021Zimmer BiometJMP Securities
Boost Price Target
5/11/2021Zimmer BiometJMP Securities
Boost Price Target
5/7/2021Coloplast A/SJPMorgan Chase & Co.
Reiterated Rating
5/5/2021Zimmer BiometTruist Securities
Boost Price Target
5/5/2021Zimmer BiometTruist
Boost Price Target
5/5/2021Zimmer BiometCanaccord Genuity
Boost Price Target
5/5/2021Zimmer BiometRaymond James
Boost Price Target
5/5/2021Zimmer BiometSVB Leerink
Boost Price Target
5/5/2021Zimmer BiometOppenheimer
Boost Price Target
4/29/2021Align TechnologySVB Leerink
Boost Price Target
4/29/2021Align TechnologyCredit Suisse Group
Boost Price Target
4/29/2021Align TechnologyStifel Nicolaus
Boost Price Target
4/29/2021Align TechnologyRobert W. Baird
Boost Price Target
4/29/2021Align TechnologyPiper Sandler
Boost Price Target
4/22/2021Align TechnologyBerenberg Bank
Upgrade
4/21/2021Edwards LifesciencesMorgan Stanley
Boost Price Target
4/21/2021Edwards LifesciencesRaymond James
Boost Price Target
4/21/2021Edwards LifesciencesWells Fargo & Company
Boost Price Target
4/21/2021Edwards LifesciencesCanaccord Genuity
Boost Price Target
4/21/2021Edwards LifesciencesPiper Sandler
Boost Price Target
4/21/2021Intuitive SurgicalCitigroup
Boost Price Target
4/21/2021Intuitive SurgicalMorgan Stanley
Boost Price Target
4/21/2021Intuitive SurgicalSVB Leerink
Boost Price Target
4/21/2021Intuitive SurgicalWells Fargo & Company
Boost Price Target
4/21/2021Intuitive SurgicalDeutsche Bank Aktiengesellschaft
Boost Price Target
4/21/2021Intuitive SurgicalJPMorgan Chase & Co.
Boost Price Target
4/21/2021Intuitive SurgicalPiper Sandler
Boost Price Target
4/15/2021Edwards LifesciencesAtlantic Securities
Initiated Coverage
4/15/2021Align TechnologySVB Leerink
Boost Price Target
4/15/2021Zimmer BiometNorthland Securities
Upgrade
4/9/2021Zimmer BiometNorthland Securities
Upgrade
4/5/2021Edwards LifesciencesEvercore ISI
Upgrade
3/9/2021Coloplast A/SCommerzbank
Upgrade
3/8/2021Coloplast A/SBarclays
Upgrade
3/8/2021Zimmer BiometOppenheimer
Boost Price Target
3/1/2021Zimmer BiometWells Fargo & Company
Boost Price Target
2/9/2021Coloplast A/SJPMorgan Chase & Co.
Reiterated Rating
2/8/2021Zimmer BiometMorgan Stanley
Boost Price Target
2/8/2021Zimmer BiometRaymond James
Boost Price Target
2/8/2021Zimmer BiometWells Fargo & Company
Boost Price Target
2/8/2021Zimmer BiometSVB Leerink
Boost Price Target
2/4/2021Align TechnologyEvercore ISI
Boost Price Target
2/4/2021Align TechnologyCredit Suisse Group
Boost Price Target
2/4/2021Align TechnologySVB Leerink
Boost Price Target
2/4/2021Align TechnologyBarclays
Boost Price Target
2/3/2021Coloplast A/SMorgan Stanley
Reiterated Rating
2/2/2021Align TechnologyPiper Sandler
Boost Price Target
1/20/2021Coloplast A/SBerenberg Bank
Upgrade
1/13/2021Coloplast A/SBarclays
Reiterated Rating
1/4/2021Align TechnologyEvercore ISI
Upgrade
12/16/2020Edwards LifesciencesSmith Barney Citigroup
Downgrade
12/14/2020Edwards LifesciencesMorgan Stanley
Boost Price Target
12/9/2020Coloplast A/SMorgan Stanley
Reiterated Rating
11/24/2020Align TechnologyCredit Suisse Group
Boost Price Target
11/24/2020Align TechnologySVB Leerink
Boost Price Target
11/24/2020Align TechnologyThe Goldman Sachs Group
Boost Price Target
11/24/2020Align TechnologyRobert W. Baird
Boost Price Target
11/23/2020Align TechnologyPiper Sandler
Boost Price Target
11/6/2020Coloplast A/SMorgan Stanley
Reiterated Rating
11/4/2020Coloplast A/SJPMorgan Chase & Co.
Reiterated Rating
10/28/2020Align TechnologyStifel Nicolaus
Boost Price Target
10/16/2020Coloplast A/SBerenberg Bank
Reiterated Rating
9/23/2020Coloplast A/SBarclays
Downgrade
9/23/2020Coloplast A/SJefferies Financial Group
Upgrade
8/19/2020Coloplast A/SJPMorgan Chase & Co.
Reiterated Rating
8/19/2020Coloplast A/SMorgan Stanley
Reiterated Rating
8/11/2020Coloplast A/SNordea Equity Research
Downgrade
4/27/2020Coloplast A/SBarclays
Reiterated Rating
4/20/2020Coloplast A/SJPMorgan Chase & Co.
Reiterated Rating
(Data available from 10/17/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.